Patrick Muller
@PatrickM42
Followers
48
Following
192
Media
0
Statuses
19
Statistician and epidemiologist, formerly of @LSHTM now at @NICEComms
London
Joined August 2011
RT @STsaftaris: Delighted to lead the #CHAIhub with @GlockerBen (@imperialcollege), @HanaChockler (@KingsCollegeLon), @MattSperrin (@Univer….
0
7
0
RT @MARCH_LSHTM: Risk of premature birth up to 50% higher in mothers with poor mental health according to 🆕 research in @TheLancetPsych 🧠….
0
9
0
RT @PLOSMedicine: Patrick Muller, Amar M Karia & colleagues investigate adverse outcomes in women with low-risk pregnancies undergoing indu….
0
2
0
RT @PLOSMedicine: Ipek Gurol-Urganci & colleagues study obstetric intervention rates and pregnancy outcomes in England during the first yea….
0
5
0
RT @nmpa_audit: Published today our sprint audit on Ethnic and Socio-economic Inequalities in Maternity and Perinatal Care. Read the report….
0
25
0
RT @ipeet: Stark racial and social inequalities in pregnancy outcomes in over a million births | LSHTM @jenejardine….
lshtm.ac.uk
Large inequalities in pregnancy outcomes between ethnic and socioeconomic groups in England, according to a nationwide study of over one million births in the English National Health Service (NHS)
0
4
0
RT @jenejardine: New paper in @TheLancet using @nmpa_audit data estimates the proportion of adverse birth outcomes (stillbirth, preterm bir….
0
83
0
Now available fully open access in AJOG: our cohort study on how 10-year reoperation risk varies between women who had different initial surgical treatments for stress urinary incontinence.
ajog.org
There is a debate about the safety and effectiveness of surgical treatments for stress urinary incontinence. Controversy about the use of synthetic mesh sling insertion has led to an increased uptake...
0
0
1
RT @MikeEhrenstein: Its taken 8 years to publication today! Thanks to the colleagues, funders and patients who made this possible. 3fold fe….
acpjournals.org
Background: B-cell depletion with rituximab is commonly used for patients with systemic lupus erythematosus (SLE) that is refractory to conventional therapy, but it yields variable responses. We...
0
32
0
RT @mugecevik: There are several reasons to think that the new UK #SARSCoV2 variant is an important one as it might be more contagious than….
0
4K
0
The BEAT-LUPUS trial analysis plan is now published! Will evaluate anti-dsDNA and flares, and whether effect of belimumab is mediated through steroid dose changes. Results later in 2020. @MikeEhrenstein @CarolinendLupus @UCL_CCTU @VersusArthritis .
trialsjournal.biomedcentral.com
Background There is limited evidence that rituximab, a B cell depletion therapy, is an effective treatment for systemic lupus erythematosus (SLE). Data on the mechanisms of B cell depletion in SLE...
0
4
12
RT @UCL_CCTU: SAP published for the KERALINK trial, testing the hypothesis that corneal cross-linking (CXL) treatment reduces the progressi….
trialsjournal.biomedcentral.com
Background The KERALINK trial tests the hypothesis that corneal cross-linking (CXL) treatment reduces the progression of keratoconus in comparison to standard care in patients aged 10–16 years. This...
0
1
0
RT @icon_lshtm: Published this week in Cancer Epidemiology 'Temporal and geographic changes in stage at diagnosis in England during 2008–20….
0
2
0
RT @Suzie_cro: Great to see the statistical analysis plan for the @TARVA_Trial published! #transparency Looking forward to seeing the resul….
0
1
0